Taylor Leavitt is Managing Partner and CEO of Leavitt Equity Partners, a healthcare focused private equity firm with over $400 million in committed capital. Mr. Leavitt brings over 20 years of healthcare and finance experience and leads execution of the LEP mission, its investment activities, and performance. This includes directing and managing the firm’s investment decisions, portfolio holdings, due diligence processes, and relationships with its investors and Partner Funds. He has managed LEP since inception, overseeing the fundraising of its three funds and deployment into 30+ portfolio companies. Taylor sits on the Board of Directors of several LEP portfolio companies in addition to serving on the Board of Directors for PACS (NYSE: PACS).

Before Leavitt Equity Partners, Taylor was a founding partner in Leavitt Partners, a healthcare consulting firm, and led its Equity Practice which advised both private equity and hedge funds on healthcare investment opportunities and industry dynamics. Prior to joining Leavitt Partners, Taylor worked for ZARS Pharma, a venture capital funded pharmaceutical company, engaged in corporate acquisitions, licensing and business development operations.

In other capacities, Taylor has worked with Epic Venture Capital, The Park City Center for Public Policy, SAIC, and Keystone Global Investment. He received a MBA from the UCLA Anderson School of Business and graduated magna cum laude from Utah State University with degrees in finance, economics and international business.